Potential biomarkers in gallbladder cancer: present status and future directions

被引：28
作者：
Srivastava, Kshitij [1 ]
Srivastava, Anvesha [2 ]
Mittal, Balraj [3 ]
机构：
[1] NHGRI, NIH, Bethesda, MD 20892 USA
[2] Univ Dist Columbia, Canc Res Lab, Dept Biol, Washington, DC USA
[3] Sanjay Gandhi Postgrad Inst Med Sci, Dept Genet, Lucknow 226014, Uttar Pradesh, India
来源：
BIOMARKERS | 2013年 / 18卷 / 01期
基金：
美国国家卫生研究院;
关键词：
Gallbladder; cancer; expression; prognosis; biomarker; BILIARY-TRACT CANCER; GROWTH-FACTOR EXPRESSION; GALL-BLADDER CANCER; GENE-EXPRESSION; PROTEOMIC ANALYSIS; MESSENGER-RNA; TUMOR-MARKER; DEFICIENT EXPRESSION; PROTEIN EXPRESSIONS; POOR-PROGNOSIS;
D O I：
10.3109/1354750X.2012.717105
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
Context: Carcinoma of the gallbladder (GBC) is the most common biliary tree cancer in the world. Beside gallstones, no specific risk factors for GBC are currently established. Several published studies have identified various prognostic gene expression markers in GBC. Objective: The present article reviewed published studies on gene expression biomarkers and gallbladder cancer susceptibility. Methods: We searched the PubMed, Medline, and Embase databases using the search terms "Gallbladder", "cancer/carcinoma", "expression", "genes", "proteins", and "biomarker" updated until June 2012 and limited to English language papers. The online searching was accompanied by checking reference lists from the identified articles for potentially eligible original reports. Results: Potential GBC biomarkers identified by different studies were summarized. Conclusion: To infer, the present article highlights a few potential biomarkers in GBC. However, none of the markers identified so far are effective as a routine screening test in GBC.
引用
收藏
页码：1 / 9
页数：9
相关论文
共 93 条
[1]   Serial analysis of gene expression identifies connective tissue growth factor expression as a prognostic biomarker in gallbladder cancer [J].
Alvarez, Hector ;
Corvalan, Alejandro ;
Roa, Juan C. ;
Argani, Pedram ;
Murillo, Francisco ;
Edwards, Jennifer ;
Beaty, Robert ;
Feldmann, Georg ;
Hong, Seung-Mo ;
Mullendore, Michael ;
Roa, Ivan ;
Ibanez, Luis ;
Pimente, Fernando ;
Diaz, Alfonso ;
Riggins, Gregory J. ;
Maitra, Anirban .
CLINICAL CANCER RESEARCH, 2008, 14 (09) :2631-2638
[2]  
Aswad B, 2002, P AN M AM SOC CLIN, V21, P13
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]   MicroRNA-Dependent Regulation of DNA Methyltransferase-1 and Tumor Suppressor Gene Expression by Interleukin-6 in Human Malignant Cholangiocytes [J].
Braconi, Chiara ;
Huang, Nianyuan ;
Patel, Tushar .
HEPATOLOGY, 2010, 51 (03) :881-890
[5]   Splice variants as cancer biomarkers [J].
Brinkman, BMN .
CLINICAL BIOCHEMISTRY, 2004, 37 (07) :584-594
[6]   Expression of MDR1 mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gall bladder cancer tissues [J].
Cao, LP ;
Duchrow, M ;
Windhövel, U ;
Kujath, P ;
Bruch, HP ;
Broll, R .
EUROPEAN JOURNAL OF CANCER, 1998, 34 (10) :1612-1617
[7]   A genome-wide association study identifies SNP in DCC is associated with gallbladder cancer in the Japanese population [J].
Cha, Pei-Chieng ;
Zembutsu, Hitoshi ;
Takahashi, Atsushi ;
Kubo, Michiaki ;
Kamatani, Naoyuki ;
Nakamura, Yusuke .
JOURNAL OF HUMAN GENETICS, 2012, 57 (04) :235-237
[8]   CA 125: A potential tumor marker for gallbladder cancer [J].
Chaube, Amita ;
Tewari, Mallika ;
Singh, Usha ;
Shukla, H. S. .
JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (08) :665-669
[9]   Autoantibody signatures: progress and perspectives for early cancer detection [J].
Desmetz, C. ;
Mange, A. ;
Maudelonde, T. ;
Solassol, J. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2011, 15 (10) :2013-2024
[10]   Movement of a novel serum tumour marker, RCAS1, in patients with biliary diseases [J].
Enjoji, M ;
Yamaguchi, K ;
Nakamuta, M ;
Nakashima, M ;
Kotoh, K ;
Tanaka, M ;
Nawata, H ;
Watanabe, T .
DIGESTIVE AND LIVER DISEASE, 2004, 36 (09) :622-627
12345678910